NCT05852717 2026-01-12
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Hoosier Cancer Research Network
Phase 2 Recruiting
Clinical Trials
22 trialsNCT02244125 2025-11-24
PCD
Institut Curie
Phase 2 Completed
NCT00801216 2024-12-10
SCNSL1
IRCCS San Raffaele
Phase 2 Completed
NCT02043847 2024-11-13
BMT-03
University of Illinois at Chicago
Phase 1 Completed
NCT06463717 2024-06-24
Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
First Affiliated Hospital of Zhejiang University
Recruiting
NCT00096460 2023-01-05
BMT CTN 0202
Medical College of Wisconsin
Phase 2/3 Terminated
NCT01141712 2023-01-04
Autologous Transplant in HIV Patients (BMT CTN 0803)
Medical College of Wisconsin
Phase 2 Completed
NCT01516593 2022-08-04
CARMEN
IRCCS San Raffaele
Phase 2 Completed
NCT00841152 2021-03-16
BAGvsTCP
Turku University Hospital
Completed
NCT04489264 2020-12-04
The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma
Peking University
Unknown
NCT01660633 2020-04-21
Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation
Acrotech Biopharma Inc.
Phase 2 Completed
NCT02043860 2019-10-14
BMT-02
University of Illinois at Chicago
Phase 1 Terminated
NCT03681938 2018-09-24
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?
Institut Paoli-Calmettes
Unknown
NCT00024466 2018-09-19
Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1/2 Completed
NCT00974623 2017-04-05
APPROACH-001
Baxter Healthcare Corporation
Terminated
NCT02353572 2015-03-09
Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
University of Colorado, Denver
Phase 1/2 Terminated
NCT00504764 2014-10-28
Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)
PETHEMA Foundation
Phase 4 Completed
NCT01716793 2012-11-01
Risk-adapted Therapy for Adult Acute Myeloid Leukemia.
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
Phase 2 Completed
NCT01112189 2011-03-24
SCL
Hospital Universitario Dr. Jose E. Gonzalez
Phase 1/2 Completed
NCT00560053 2008-11-27
Pethema Multiple Myeloma 2000
PETHEMA Foundation
Phase 3 Completed
NCT00435955 2007-02-16
Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma
Azienda Ospedaliera San Giovanni Battista
Phase 3 Unknown
NCT00140569 2005-09-01
Randomized Study for Patients With Follicular Lymphoma Needing Treatment
Lymphoma Study Association
Phase 3 Completed